...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

Koo,, I am waiting to hear back if the shares are registered by computerserve,,and the owner gets the voting rights etc.,,that would be a strong indication as to legitamacy...just thinking..!,,I assume the OTC owners of shares here have voted.

Share
New Message
Please login to post a reply